Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Liliestol Research LLC
mi
from
Fargo, ND
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Liliestol Research LLC
mi
from
Fargo, ND
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
New Horizons Clinical Research
mi
from
Cincinnati, OH
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
New Horizons Clinical Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Remington Davis Inc.
mi
from
Columbus, OH
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Remington Davis Inc.
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Sridhar Guduri, MD
mi
from
Dublin, OH
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Sridhar Guduri, MD
mi
from
Dublin, OH
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
IPS Research Company
mi
from
Oklahoma City, OK
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Allergy Associates Research Center
mi
from
Portland, OR
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Allergy Associates Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Lowcountry Lung & Critical Care, PA
mi
from
Charleston, SC
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Lowcountry Lung & Critical Care, PA
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Easley Clinical Research
mi
from
Easley, SC
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Easley Clinical Research
mi
from
Easley, SC
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Gaffney Pharmaceutical Research
mi
from
Gaffney, SC
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Gaffney Pharmaceutical Research
mi
from
Gaffney, SC
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Spectrum Medical Research, LLC
mi
from
Gaffney, SC
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Spectrum Medical Research, LLC
mi
from
Gaffney, SC
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
CU Pharmaceutical Research
mi
from
Rock Hill, SC
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
CU Pharmaceutical Research
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Hope Clinical Research
mi
from
Seneca, SC
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Hope Clinical Research
mi
from
Seneca, SC
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
New Phase Research & Development
mi
from
Knoxville, TN
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
New Phase Research & Development
mi
from
Knoxville, TN
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Health Research of Hampton Roads
mi
from
Newport News, VA
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Health Research of Hampton Roads
mi
from
Newport News, VA
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Pulmonary Associates of Richmond, Inc
mi
from
Richmond, VA
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Pulmonary Associates of Richmond, Inc
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
MultiCare Pulmonary Specialists
mi
from
Tacoma, WA
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
MultiCare Pulmonary Specialists
mi
from
Tacoma, WA
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Ribo Research, LLC dba Peninsula Research, Inc.
mi
from
Ormond Beach, FL
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Ribo Research, LLC dba Peninsula Research, Inc.
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Asthma & Allergy Center of Chicago, SC
mi
from
River Forest, IL
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Asthma & Allergy Center of Chicago, SC
mi
from
River Forest, IL
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
CARE Clinical Research
mi
from
Saint Louis, MO
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
CARE Clinical Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
The Clinical Research Center, LLC
mi
from
Saint Louis, MO
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
The Clinical Research Center, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated:  2/13/2018
Clinical Research of Charleston
mi
from
Mount Pleasant, SC
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Status: Enrolling
Updated: 2/13/2018
Clinical Research of Charleston
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Bougie Use in Emergency Airway Management
Bougie Use in Emergency Airway Management
Status: Enrolling
Updated:  2/13/2018
Hennepin County Medical Center
mi
from
Minneapolis, MN
Bougie Use in Emergency Airway Management
Bougie Use in Emergency Airway Management
Status: Enrolling
Updated: 2/13/2018
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The Effect of Nebulized Albuterol on Donor Oxygenation
The Effect of Nebulized Albuterol on Donor Oxygenation
Status: Enrolling
Updated:  2/14/2018
California Transplant Donor Network
mi
from
Oakland, CA
The Effect of Nebulized Albuterol on Donor Oxygenation
The Effect of Nebulized Albuterol on Donor Oxygenation
Status: Enrolling
Updated: 2/14/2018
California Transplant Donor Network
mi
from
Oakland, CA
Click here to add this to my saved trials
Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
Open-Label, Feasibility Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated:  2/14/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
Open-Label, Feasibility Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated: 2/14/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Phoenix Children's Hospital
mi
from
Phoenix, AZ
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Riley Children's Hospital
mi
from
Indianapolis, IN
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Hackensack University Medical Center
mi
from
Hackensack, NJ
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Maria Fareri Childrens Hospital
mi
from
Valhalla, NY
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Maria Fareri Childrens Hospital
mi
from
Valhalla, NY
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Rainbow Babies Hospital
mi
from
Cleveland, OH
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Rainbow Babies Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
St. Jude Children's Research Hospital
mi
from
Memphis, TN
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Texas Children's Hospital
mi
from
Houston, TX
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Weill Cornell Medical Center
mi
from
New York, NY
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Hospital Sainte Justine
mi
from
Montreal,
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Hospital Sainte Justine
mi
from
Montreal,
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
University of California at San Francisco
mi
from
San Francisco, CA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Status: Enrolling
Updated:  2/16/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Status: Enrolling
Updated: 2/16/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.
Status: Enrolling
Updated:  2/19/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.
Status: Enrolling
Updated: 2/19/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.
Status: Enrolling
Updated:  2/19/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.
Status: Enrolling
Updated: 2/19/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated:  2/20/2018
Columbia University Medical Center Children's Hospital
mi
from
New York, NY
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated: 2/20/2018
Columbia University Medical Center Children's Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated:  2/20/2018
University of North Carolina, North Carolina Children's Hospital
mi
from
Chapel Hill, NC
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated: 2/20/2018
University of North Carolina, North Carolina Children's Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated:  2/20/2018
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated: 2/20/2018
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated:  2/20/2018
Connecticut Children's Medical Center
mi
from
Hartford, CT
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated: 2/20/2018
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated:  2/20/2018
Riley Hospital for Children
mi
from
Indianapolis, IN
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated: 2/20/2018
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated:  2/20/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated: 2/20/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated:  2/20/2018
Children's Medical Center
mi
from
Dallas, TX
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation
Status: Enrolling
Updated: 2/20/2018
Children's Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials